The Lancet




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Dengue: the threat to health now and in the future

doi : 10.1016/S0140-6736(24)01542-3

Volume 404, Issue 10450, 27 July–2 August 2024, Page 311

Buy The Package and View The Article Online


Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma

Andrew M Evens a

doi : 10.1016/S0140-6736(24)01404-1

Buy The Package and View The Article Online


CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma

Maria-Luisa Schubert a, Peter Dreger a

doi : 10.1016/S0140-6736(24)00815-8

Buy The Package and View The Article Online


Self-guided digital acceptance and commitment therapy as a treatment option for fibromyalgia

Guilherme Torres Vilarino

doi : 10.1016/S0140-6736(24)01133-4

Buy The Package and View The Article Online


Unlocking the power of NHS research: a priority for the new UK Government

Andrew Morris a

doi : 10.1016/S0140-6736(24)01451-X

Buy The Package and View The Article Online


The CONCORD–Lancet Global Commission on Cancer

Claudia Allemani a, Gulnar Azevedo e Silva b, Prashant Mathur c, Michel P Coleman a

doi : 10.1016/S0140-6736(24)01345-X

Buy The Package and View The Article Online


Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions

Anthony Muchai Manyara a b, Oriana Ciani c, Rod S Taylor a d, SPIRIT-Surrogate and CONSORT-Surrogate Project team and Consensus Group

doi : 10.1016/S0140-6736(24)01306-0

Buy The Package and View The Article Online


Charges brought in Brazilian COVID-19 malpractice case

Marcia Triunfol

doi : 10.1016/S0140-6736(24)01543-5

Buy The Package and View The Article Online


Why aren't the Republicans talking about health?

Susan Jaffe

doi : 10.1016/S0140-6736(24)01544-7

Buy The Package and View The Article Online


AbbVie to face potentially groundbreaking case over Humira

Ferry Biedermann

doi : 10.1016/S0140-6736(24)01545-9

Buy The Package and View The Article Online


Kathleen Maletic Neuzil: new Fogarty International Center leader

Udani Samarasekera

doi : 10.1016/S0140-6736(24)01453-3

Buy The Package and View The Article Online


Public health and gun violence

Mary T Bassett

doi : 10.1016/S0140-6736(24)01496-X

Buy The Package and View The Article Online



Increasing diversity among physicians

Cass Condray a

doi : 10.1016/S0140-6736(24)01245-5

Buy The Package and View The Article Online


Tackling Japan's population crisis by improving the childcare environment

Aiju Koyama a, Akihiko Ozaki b, Arinobu Hori c, Tetsuya Tanimoto d

doi : 10.1016/S0140-6736(24)01175-9

Buy The Package and View The Article Online


Peer learning in immunisation programmes

Abdu A Adamu a, Duduzile Ndwandwe b, Rabiu I Jalo c, Modjirom Ndoutabe a, Charles S Wiysonge a b d

doi : 10.1016/S0140-6736(24)01340-0

Buy The Package and View The Article Online


Trade unions as public health actors

Jacques Wels a b

doi : 10.1016/S0140-6736(23)02808-8

Buy The Package and View The Article Online


CAR T-cell perspectives in lupus

Elisa Gremese a, Dario Bruno a, Gianfranco Ferraccioli a

doi : 10.1016/S0140-6736(24)01267-4

Buy The Package and View The Article Online


CAR T-cell perspectives in lupus – Authors' reply

Georg Schett a c, Andreas Mackensen b c, Dimitrios Mougiakakos d e

doi : 10.1016/S0140-6736(24)01266-2

Buy The Package and View The Article Online


Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Yakup Ergun a

doi : 10.1016/S0140-6736(24)01045-6

Buy The Package and View The Article Online


Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Yilin Gu a

doi : 10.1016/S0140-6736(24)01046-8

Buy The Package and View The Article Online


Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Andrea Messori a

doi : 10.1016/S0140-6736(24)01047-X

Buy The Package and View The Article Online


Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Kayo Harada a, Akihiko Ozaki b c, Tetsuya Tanimoto c d

doi : 10.1016/S0140-6736(24)01048-1

Buy The Package and View The Article Online


Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial – Authors' reply

Hope S Rugo a, Aditya Bardia b, Sara Tolaney c

doi : 10.1016/S0140-6736(24)01049-3

Buy The Package and View The Article Online



Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Prof Peter Borchmann MD a b c d , Justin Ferdinandus MD a b c d , Gundolf Schneider MA a b c d , Alden Moccia MD e f , Prof Richard Greil MD g h i , Prof Mark Hertzberg MD j k , Valdete Schaub MD l , Prof Andreas Hüttmann MD m , Prof Felix Keil MD n , Prof Judith Dierlamm MD o , Mathias Hänel MD p , Prof Urban Novak MD e q , Julia Meissner MD r , Andreas Zimmermann MD s , Prof Stephan Mathas MD t u v w , Prof Josée M Zijlstra MD PhD x , Alexander Fosså MD y z , Prof Andreas Viardot MD aa , Prof Bernd Hertenstein MD ab , Sonja Martin MD ac … Prof Volker Diehl MD a b c d

doi : 10.1016/S0140-6736(24)01315-1

Buy The Package and View The Article Online


CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Matthew J Frank MD a c *, John H Baird MD d *, Anne Marijn Kramer MD a c e *, Hrishikesh K Srinagesh MD a, Shabnum Patel PhD c, Annie Kathleen Brown MS c, Jean S Oak MD f, Sheren F Younes PhD f, Yasodha Natkunam MD f, Mark P Hamilton MD a c, Yi-Jiun Su MD a g, Neha Agarwal MS a, Harshini Chinnasamy MS c, Emily Egeler PhD c, Sharon Mavroukakis MS c, Steven A Feldman PhD c, Bita Sahaf PhD c, Prof Crystal L Mackall MD a b c, Lori Muffly MD c, Prof David B Miklos MD a c…Ramya Tunuguntla

doi : 10.1016/S0140-6736(24)00746-3

Buy The Package and View The Article Online


Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial

R Michael Gendreau MD PhD a , Prof Lance M McCracken PhD b , Prof David A Williams PhD c , Juan V Luciano PhD d e f , Yifei Dai PhD g , Nicolette Vega BA g , Zunera Ghalib BS g , Kristen Guthrie BS g , Allison C Kraus MA g , Michael J Rosenbluth PhD g , Ben Vaughn MS h , Jennifer M Zomnir MD i , Dana Reddy MD j , Prof Andrea L Chadwick MD k , Prof Daniel J Clauw MD c , Prof Lesley M Arnold MD l

doi : 10.1016/S0140-6736(24)00909-7

Buy The Package and View The Article Online


A visual diagnosis of phaeochromocytoma crisis characterised by cyclic fluctuations of blood pressure: be on the look-out for rapid changes

Martin Wernhart MD a, Clemens Wiesinger MD b, Martin Windpessl MD c, Lisa Madl-Liebenberger MD a, Elisabeth Lassnig MD a, Ronald K Binder MD a, Thomas Weber MD a

doi : 10.1016/S0140-6736(24)00849-3

Buy The Package and View The Article Online


Infective endocarditis

Mingfang Li MD a, Joon Bum Kim MD b, B K S Sastry MD c, Prof Minglong Chen MD a

doi : 10.1016/S0140-6736(24)01098-5

Buy The Package and View The Article Online


Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment

Prof Torsten Zuberbier MD a b, Luis Felipe Ensina MD c, Ana Giménez-Arnau MD d, Clive Grattan MD e, Emek Kocatürk MD a b f, Kanokvalai Kulthanan MD g, Pavel Kolkhir MD a b †, Marcus Maurer MD a b †

doi : 10.1016/S0140-6736(24)00852-3

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?